Genesys International Corporation Limited has opened its rights issue to eligible equity shareholders, aiming to raise ₹1,253.7 crore by issuing 2,50,74,226 fully paid-up equity shares. The issue, priced at ₹50 per share (including a premium of ₹45), is available in the ratio of three rights equity shares for every five existing shares held as of the record date, August 06, 2026. This capital raise allows existing investors to maintain their proportional ownership while providing the company with fresh capital.

The issue period runs from Friday, August 14, 2026, to Friday, August 21, 2026. Shareholders who wish to exit their entitlements can renounce them on the secondary market platform of BSE and NSE between August 14 and Tuesday, August 18, 2026. Off-market transfers must be completed such that the rights entitlements are credited to the renouncee’s demat account before the issue closing date. All applications must be made through the Applications Supported by Blocked Amount (ASBA) process, as mandated under Regulation 76 of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018.

Issue Programme and Key Dates

The Board reserves the right to extend the issue period by up to 30 days from the opening date if necessary. No withdrawal of applications will be permitted after the issue closing date. Rights entitlements that are neither subscribed nor renounced by the closing date will lapse and be extinguished.

Application Process and Eligibility

Investors are required to use the ASBA facility to apply for the rights shares. Applicants must have an ASBA-enabled bank account with a Self-Certified Syndicate Bank (SCSB). The application form can be submitted to the designated branch of the SCSB or via online banking platforms. For shareholders holding physical shares, it is mandatory to provide demat account details to the registrar or the company at least two working days prior to the issue closing date; failure to do so will render them ineligible to apply.

Bigshare Services Private Limited acts as the registrar to the issue. Shareholders can check their rights entitlements on the registrar’s website using their DP ID, Client ID, or Folio Number along with their PAN. The allotment of shares will be made only in dematerialized form.

What the Numbers Show

The rights issue represents a significant capital injection relative to the company’s existing equity base, with an aggregate amount of ₹1,253.7 crore assuming full subscription. The pricing of ₹50 per share implies a substantial premium over the face value of ₹5, reflecting the market valuation attached to the new equity. The inclusion of a dedicated trading window for renunciation (August 14–18) provides liquidity for shareholders who may not wish to participate financially but want to monetize their entitlements before they lapse.

Genesys International Corporation Limited company name has finalized the key terms of its equity rights issue, setting the subscription price at ₹50 per share and targeting a raise of up to ₹12,537.11 lakhs. The Rights Issue Committee approved these details on July 31, 2026, confirming an offer of 2,50,74,226 fully paid-up equity shares to existing shareholders. This capital raise aims to strengthen the company’s balance sheet, with the record date fixed for August 06, 2026, determining eligibility for participation.

The decision follows initial board approval in June and in-principle clearance from both BSE Limited and the National Stock Exchange of India Ltd. received on July 27, 2026. The committee’s meeting concluded with a definitive structure for the issuance, including the entitlement ratio and timeline for subscription. Shareholders holding stock on the record date will receive rights to purchase new shares at a premium of ₹45 over the face value of ₹5.

Key Terms of the Rights Issue

The finalized parameters define the mechanics of the offer, ensuring clarity for eligible investors regarding their entitlements and the subscription window.

Entitlement and Fractional Share Rules

Eligibility is determined by holdings as of the record date. The company has specified strict rules for fractional entitlements to ensure fair distribution. Holdings less than five shares or not in multiples of five will result in ignored fractional entitlements. However, these shareholders may receive preferential consideration for one additional share if they apply for shares beyond their rights entitlement, subject to availability.

Shareholders with fewer than five shares have zero entitlement but can apply for additional shares, receiving preference for one extra share if available. These applications are non-negotiable and cannot be renounced to third parties. The ISIN for dematerialized rights entitlement is INE727B20018.

Capital Structure Impact

The rights issue will significantly expand the company’s outstanding equity base. Prior to the issuance, Genesys had 4,17,90,377 fully paid-up equity shares. Assuming full subscription, the post-issue capital structure will comprise 6,68,64,603 shares. This expansion dilutes existing ownership percentages but provides the company with substantial fresh capital for operational needs or debt reduction.

What the Numbers Show

The pricing at ₹50 represents a significant premium over the ₹5 face value, indicating management’s confidence in the company’s intrinsic value and future prospects. The ability to raise over ₹12,500 lakhs through a rights issue suggests strong shareholder support and liquidity in the market. The structured approach to fractional entitlements minimizes administrative complexity while offering limited recourse to small holders, balancing efficiency with fairness.

Regulatory Compliance and Next Steps

The disclosure was made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Kushal Jain, Company Secretary & Compliance Officer, signed the notice submitted to both stock exchanges. The issue window opens on August 14, 2026, with an on-market renunciation period running until August 18, 2026. The closing date is August 21, 2026, though the Board retains the right to extend this by up to 30 days from the opening date if necessary.